KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

USA Compression Partners (USAC) Cash & Equivalents (2016 - 2025)

USA Compression Partners (USAC) has disclosed Cash & Equivalents for 14 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 61071.43% to $8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.6 million, a 61071.43% increase, with the full-year FY2025 number at $8.6 million, up 61071.43% from a year prior.
  • Cash & Equivalents was $8.6 million for Q4 2025 at USA Compression Partners, up from $2000.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $8.6 million in Q4 2025 to a low of $2000.0 in Q2 2021.
  • A 5-year average of $537588.2 and a median of $11000.0 in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 97.6% in 2022, then surged 61071.43% in 2025.
  • USA Compression Partners' Cash & Equivalents stood at $250000.0 in 2021, then plummeted by 86.0% to $35000.0 in 2022, then plummeted by 68.57% to $11000.0 in 2023, then rose by 27.27% to $14000.0 in 2024, then soared by 61071.43% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for USAC's Cash & Equivalents are $8.6 million (Q4 2025), $2000.0 (Q2 2025), and $2000.0 (Q1 2025).